Director/PDMR Shareholding

RNS Number : 2903L

Creo Medical Group PLC

09 September 2021

 

Creo Medical Group plc

("Creo" or the "Company")

Director/PDMR Shareholding

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that Charles Spicer, Non-Executive Chairman, purchased 9,657 Ordinary Shares through the Open Offer at the Offer Price of 182.5 pence per Ordinary Share   via his Self-Invested Personal Pension ('SIPP') .  Following this purchase and Admission of the New Ordinary Shares on 7 September 2021 Charles Spicer holds 127,976 Ordinary Shares in the Company via his SIPP, representing approximately 0.07% of the Company's issued share capital.  

Capitalised terms used, but not defined in this announcement shall have the same meaning as set out in the Circular dated 16 August 2021.

Creo Medical Group plc	investors.creomedical.com
Richard Rees (CFO)	[phone]
Cenkos Securities plc	[phone]
Stephen Keys / Camilla Hume (NOMAD)
Michael Johnson / Russell Kerr (Sales)
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus / Lianne Cawthorne	Mob: [phone]

The information below, set out in accordance with the requirements of the MAR, provides further detail. 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Charles Spicer
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Creo Medical Group plc
b)	LEI	213800H188ZDCWWXFA21
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of £0.001 each GB00BZ1BLL44
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 182.5p 9,657
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	7 September 2021
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHFLFFIAIIAIIL